Sight Sciences, Inc. financial data

Symbol
SGHT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4040 Campbell Ave,, Suite 100, Menlo Park, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.23K % -1.87%
Quick Ratio 59.6 % +43.9%
Debt-to-equity 41.6 % +25%
Return On Equity -45.7 % +0.93%
Return On Assets -32.3 % +6.73%
Operating Margin -65.4 % +25.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.3M shares +3.4%
Common Stock, Shares, Outstanding 50.1M shares +3.06%
Entity Public Float 302M USD +4.07%
Common Stock, Value, Issued 50K USD +2.04%
Weighted Average Number of Shares Outstanding, Basic 49.9M shares +2.82%
Weighted Average Number of Shares Outstanding, Diluted 49.9M shares +2.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 79.4M USD -2.6%
Research and Development Expense 16.6M USD -21.5%
Operating Income (Loss) -51.9M USD +27.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -52.2M USD +26.4%
Income Tax Expense (Benefit) 120K USD +135%
Net Income (Loss) Attributable to Parent -52.3M USD +26.3%
Earnings Per Share, Basic -1.07 USD/shares +26.7%
Earnings Per Share, Diluted -1.07 USD/shares +26.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 118M USD -23.5%
Accounts Receivable, after Allowance for Credit Loss, Current 19.9M USD +10%
Inventory, Net 6.78M USD -14.2%
Assets, Current 146M USD -19.7%
Property, Plant and Equipment, Net 1.49M USD +0.81%
Operating Lease, Right-of-Use Asset 1.26M USD +11.7%
Other Assets, Noncurrent 640K USD +74.4%
Assets 150M USD -19.2%
Accounts Payable, Current 1.92M USD -34.7%
Employee-related Liabilities, Current 5.39M USD -5.7%
Accrued Liabilities, Current 3.77M USD +40.5%
Liabilities, Current 13.3M USD -5.44%
Operating Lease, Liability, Noncurrent 747K USD +598%
Other Liabilities, Noncurrent 1.02M USD -32%
Liabilities 48.1M USD -2.2%
Retained Earnings (Accumulated Deficit) -323M USD -19.3%
Stockholders' Equity Attributable to Parent 102M USD -25.3%
Liabilities and Equity 150M USD -19.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.79M USD +43.7%
Net Cash Provided by (Used in) Financing Activities -942K USD -504%
Net Cash Provided by (Used in) Investing Activities -117K USD +7.14%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 50.1M shares +3.06%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.8M USD +38.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 118M USD -23.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.05M USD +5.19%
Deferred Tax Assets, Valuation Allowance 74.7M USD +21.9%
Deferred Tax Assets, Gross 75M USD +21.7%
Operating Lease, Liability 1.26M USD +7.17%
Depreciation 614K USD +15.6%
Payments to Acquire Property, Plant, and Equipment 117K USD -7.14%
Lessee, Operating Lease, Liability, to be Paid 1.44M USD +12.8%
Property, Plant and Equipment, Gross 3.4M USD +22.2%
Operating Lease, Liability, Current 508K USD -52.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 618K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 321K USD -51.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 181K USD +77.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 497K USD
Deferred Tax Assets, Operating Loss Carryforwards 60.8M USD +15.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 903K USD +21.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 988K USD +0.82%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 192K USD +31.5%
Deferred Tax Assets, Net of Valuation Allowance 381K USD -9.72%
Share-based Payment Arrangement, Expense 16.1M USD +17.6%
Interest Expense 5.13M USD +3.05%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%